What is Stryker's cash & equivalents?

Stryker (SYK) reported cash & equivalents of $2.88B in Q1 2026.

How has Stryker's cash & equivalents changed year-over-year?

Stryker's cash & equivalents increased by 24.1% year-over-year, from $2.32B to $2.88B.

What is the long-term trend for Stryker's cash & equivalents?

Over 5 years (2020 to 2025), Stryker's cash & equivalents has grown at a 6.4% compound annual growth rate (CAGR), from $2.94B to $4.01B.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Stryker SYK Cash & Equivalents

Cash & Equivalents at other companies

Baxter InternationalBAX

$2.02B-12.1%

Johnson & JohnsonJNJ

$20.42B+9.9%

AxogenAXGN

$84.65M+251%

CONMEDCNMD

$35.03M-1.3%

Merit Medical SystemsMMSI

$488.08M+23.4%

Orthofix Medical Inc.OFIX

$120.28M+108%

Other financials

Income statement

See full

Revenue$6.0B+2.6%

Gross profit$3.8B+1.8%

Operating income$936.0M+11.8%

Net income$745.0M+13.9%

EPS (diluted)$1.93+14.2%

Balance sheet

See full

Total debt$14.4B-15.1%

Total assets$46.3B+0.6%

Cash flow

See full

Operating cash flow$581.0M+132%

CapEx$166.0M+35.0%

Free cash flow$415.0M+227%

Valuation

See full

Market cap$126.6B-17.3%

Enterprise value$138.11B-17.5%

P/E37.9×-14.5×

P/S5×-1.4×

Profitability

See full

Gross margin63.8%-0.1pp

Operating margin19.7%+4.4pp

Net margin13.2%+0.9pp

FCF margin18.1%+2.7pp

Returns & leverage

See full

Return on equity32.8%—

Debt / equity0.8×—

Current ratio2.1×+0.5×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Stryker’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stryker's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Stryker's cash & equivalents?: Stryker (SYK) reported cash & equivalents of $2.88B in Q1 2026.
How has Stryker's cash & equivalents changed year-over-year?: Stryker's cash & equivalents increased by 24.1% year-over-year, from $2.32B to $2.88B.
What is the long-term trend for Stryker's cash & equivalents?: Over 5 years (2020 to 2025), Stryker's cash & equivalents has grown at a 6.4% compound annual growth rate (CAGR), from $2.94B to $4.01B.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.